Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

ALLISON, JAMES P

One or more keywords matched the following items that are connected to ALLISON, JAMES P

Item Type	Name
Concept	Cancer Vaccines
Academic Article	SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.
Academic Article	Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma.
Academic Article	The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.
Academic Article	Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors.
Academic Article	Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses.
Academic Article	CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.
Academic Article	Retrospective. Lloyd J. Old (1933-2011).
Academic Article	Prostate cancer: advances in immunotherapy.
Academic Article	Checkpoint blockade in cancer immunotherapy.
Academic Article	CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.
Academic Article	The B7 family and cancer therapy: costimulation and coinhibition.
Academic Article	CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.
Academic Article	PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.
Academic Article	Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy.
Academic Article	Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.
Academic Article	Cytotoxic T lymphocyte antigen-4 blockade enhances antitumor immunity by stimulating melanoma-specific T-cell motility.
Academic Article	Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.
Academic Article	Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Academic Article	De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute.
Academic Article	Frontiers in cancer immunotherapy-a symposium report.
Academic Article	Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer.

Search Criteria

Cancer Vaccines